Tetra Bio Pharma Inc (TBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2020 | 11-2019 | 08-2019 | 05-2019 | 02-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 7 | 27 | -4 | 2 | 2 |
| Accounts receivable | -5 | 20 | 1,376 | -1,100 | 169 |
| Other Working Capital | 1,120 | -37 | 2,394 | -329 | -2,035 |
| Other Operating Activity | -4,177 | -5,042 | -6,923 | -1,810 | -4,053 |
| Operating Cash Flow | $-3,055 | $-5,033 | $-3,157 | $-3,237 | $-5,917 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -398 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -255 | 0 | 0 | 0 |
| Investing Cash Flow | $-415 | $-255 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,500 | -261 | 8,311 | N/A | N/A |
| Other Financing Activity | -2,044 | 2,261 | -883 | 100 | 200 |
| Financing Cash Flow | $13,456 | $2,000 | $7,428 | $100 | $200 |
| Beginning Cash Position | 2,038 | 5,571 | 1,299 | 7,868 | 13,586 |
| End Cash Position | 11,972 | 2,038 | 5,571 | 1,299 | 7,868 |
| Net Cash Flow | $9,986 | $-3,287 | $4,271 | $-6,569 | $-5,717 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,055 | -5,033 | -3,157 | -3,237 | -5,917 |
| Capital Expenditure | -415 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,471 | -5,033 | -3,157 | -3,237 | -5,917 |